Skip to main content
. 2021 May 22;2021(5):CD012721. doi: 10.1002/14651858.CD012721.pub3

EUCTR2005‐002109‐22.

Methods Parallel RCT
Participants 99 participants with symptomatic chronic heart failure proven by echocardiography or Tc‐Szintigraphy ( EF <45%).
Interventions Telmisartan versus candesartan versus additional treatment
Outcomes Insulin sensitivity; correaltion between natriuretic peptides ( as a surrogate for severity of heart failure) and impaired glucosemetabolism
Notes Subgroup of interest. Trial status is completed (30 September 2008) but unable to find results. No contact details for investigator.